You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-CCR5 antibody
See all CCR5 products (25) ...

Description

Goat polyclonal to CCR5

Specificity

This antibody binds to CCR 5 receptors on human peripheral blood leukocytes as determined by immunocytochemistry.

Tested applications

IHC-Fr, WB, IHC-P, ICCmore details

Cross reactivity

Reacts with

Human, Macaque Monkey

Immunogen

Synthetic peptide: YQVSSPIYDINYYTSEPCQKINVKQIAA, corresponding to N terminal amino acids 3-30 of Human CCR5.

YQVSSPIYDI NYYTSEPCQK INVKQIAA

Positive control

Human peripheral blood cells or paraffin sections of spleen.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

PBS, 1mg/ml BSA, 0.1% sodium azide, pH7.2

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • - CCR5 antibody (ab1673)- CCR5 antibody (ab1673) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab1673 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ShowHide

    IHC-Fr

     IHC-Fr: Use at an assay ...Read more →

    IHC-Fr: Use at an assay dependent dilution.

  • WB

     WB: 1/1000

    WB: 1/1000

  • ShowHide

    IHC-P

     IHC-P: 1/300(with biotin...Read more →

    IHC-P: 1/300(with biotinylated secondary and streptavidin-HRP. )

  • ICC

     ICC: 1/300

    ICC: 1/300

Target

Function

Receptor for a number of inflammatory CC-chemokines including MIP-1-alpha, MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation. Acts as a coreceptor (CD4 being the primary receptor) for HIV-1 R5 isolates.

Tissue specificity

Highly expressed in spleen, thymus, in the myeloid cell line THP-1, in the promyeloblastic cell line KG-1A and on CD4+ and CD8+ T-cells. Medium levels in peripheral blood leukocytes and in small intestine. Low levels in ovary and lung.

Involvement in disease

Genetic variation in CCR5 is associated with suseptibility to diabetes mellitus insulin-dependent type 22 (IDDM22) [MIM:612522]. A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical fetaures are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.

Sequence similarities

Belongs to the G-protein coupled receptor 1 family.

Post-translational
modifications

Sulfated on at least 2 of the N-terminal tyrosines. Sulfation contributes to the efficiency of HIV-1 entry and is required for efficient binding of the chemokines, CCL3 and CCL4.
O-glycosylated, but not N-glycosylated. Ser-6 appears to be the major site. Also sialylated glycans present which contribute to chemokine binding. Thr-16 and Ser-17 may also be glycosylated and, if so, with small moieties such as a T-antigen.
Palmitoylation in the C-terminal is important for cell surface expression, and to a lesser extent, for HIV entry.
Phosphorylation on serine residues in the C-terminal is stimulated by binding CC chemokines especially by APO-RANTES.

Cellular localization

Cell membrane.

Target information above from: UniProt accessionP51681 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • AM4 7 antibody
  • C C chemokine receptor type 5 antibody
  • C C CKR 5 antibody
  • C-C chemokine receptor type 5 antibody
  • C-C CKR-5 antibody
  • C-C motif chemokine receptor 5 A159A antibody
  • CC Chemokine Receptor 5 antibody
  • CC Chemokine Receptor Type 5 antibody
  • CC CKR 5 antibody
  • CC-CKR-5 antibody
  • CCCKR 5 antibody
  • CCCKR5 antibody
  • CCR 5 antibody
  • CCR-5 antibody
  • CCR5 antibody
  • CCR5 chemokine (C C motif) receptor 5 antibody
  • CCR5_HUMAN antibody
  • CD 195 antibody
  • CD195 antibody
  • CD195 Antigen antibody
  • Chemokine C C motif receptor 5 antibody
  • Chemokine receptor CCR5 antibody
  • CHEMR13 antibody
  • CKR 5 antibody
  • CKR5 antibody
  • CMKBR 5 antibody
  • CMKBR5 antibody
  • FLJ78003 antibody
  • HIV 1 Fusion Coreceptor antibody
  • HIV-1 fusion coreceptor antibody
  • HIV1 fusion coreceptor antibody
  • IDDM22 antibody
  • MIP-1 alpha receptor antibody
see all

Anti-CCR5 antibody images:

  - CCR5 antibody (ab1673)

- CCR5 antibody (ab1673)

Immunohistochemistry using ab1673 on a section of normal human spleen 

References for Anti-CCR5 antibody (ab1673)

This product has been referenced in:

  • Zimmermann Tet al. Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration. Int J Colorectal Dis 25:417-24 (2010). WB, IHC-P; Human.Read more (PubMed: 20054600) »
  • Tan MCet al. Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol 182:1746-55 (2009). IHC-P; Human.Read more (PubMed: 19155524) »

See all 4 publications for this product

Publishing research using ab1673? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"